Company Data
Merus N.V.
Ticker
MRUS
Current Price
$94.85 0.51%
Market Cap
$7.2B
Price Target
Refer to Report
Volume
2.3M
52wk Range
$33.19 - $94.63
Overview
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus operates in one reportable segment, which comprises the discovery and development of innovative bispecific therapeutics.